Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Med...(t guides the surgeon's moves during thel...),Health

Date:7/22/2008

t guides the surgeon's moves during the laser treatment and a sterile sheath for working in the operating room. EkkyLite(TM) activates and stimulates the skin regeneration process resulting in faster healing, while preventing, reducing and sometimes completely erasing surgical scars.

The therapeutic, aesthetic and practical benefits provided by EkkyLite(TM) makes it the first laser technology accessible to all surgeons: not only plastic surgeons but also specialists experiencing scarring issues such as dermatologists, obstetricians, trauma specialists...

Currently in clinical phase, the commercialization of the Ekkylite(TM) system is forecasted for 2008 in France and for 2009 successively in Europe and the United States. Based in Meyreuil, France, Ekkyo has 8 staff members as of December 2007.

More on http://www.ekkyo.com

*Alexandre C. Capon et al. LSM-08-0066 (20657)

Lasers in Surgery and Medicine publishes the highest quality research and clinical manuscripts in areas relating to the use of lasers in medicine and biology. The journal publishes basic and clinical studies on the therapeutic and diagnostic use of lasers in all the surgical and medical specialties.

'/>"/>

SOURCE EKKYO Copyright©2008 PR Newswire. All rights reserved

1 GOOD

Page: 1 2 3
Related medicine technology :

1. Latest Cell Publication Describes the Novel Kinase Regulators Using OriGenes Functional Kinome Collection
2. Wacker Validates Scalability of Anticalin(R) Production With E.coli Secretion Technology and Will Produce Pieris First Clinical Candidate PRS-050
3. Bapineuzumab To Become the First-to-Market Disease-Modifying Alzheimers Drug After Flurizans Discontinuation
4. Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company
5. Sonablate(R) International HIFU Registry is the First Worldwide HIFU Clinical Registry for Prostate Cancer Treatments
6. Patient Receives vProtect(TM) Luminal Shield in First-Ever Vulnerable Plaque Clinical Trial
7. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
8. First Breast Cancer Patient Receives Treatment in National Electronic Brachytherapy Registry Launched by Three Physician Societies
9. Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference
10. Accumetrics Announces the Launch and First Patient Enrolled Into the GRAVITAS Trial
11. Fox Chase Cancer Center and VisEn Medical Announce Program to Advance First Clinical Trials of Novel Fluorescence Molecular Imaging Technologies